Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
1,788 SEK | +1,94% | -1,76% | +0,90% |
Omzet 2021 | 844K 76,92K 72,25K | Omzet 2022 | 1,14 mln. 104K 98,02K | Marktkapitalisatie | 595 mln. 54,25 mln. 50,95 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2021 | -156 mln. -14,22 mln. -13,35 mln. | Nettowinst (verlies) 2022 | -168 mln. -15,31 mln. -14,38 mln. | EV/omzet 2021 | 1.710 x |
Nettoliquiditeiten 2021 | 254 mln. 23,16 mln. 21,76 mln. | Nettoliquiditeiten 2022 | 68,47 mln. 6,24 mln. 5,86 mln. | EV/omzet 2022 | 460 x |
K/w-verhouding 2021 |
-10,9
x | K/w-verhouding 2022 |
-3,54
x | Werknemers | 11 |
Dividendrendement 2021 * |
-
| Dividendrendement 2022 |
-
| Vrij verhandelbaar | 75,34% |
Recentste transcriptie over Immunovia AB
1 dag | +1,94% | ||
1 week | -1,76% | ||
Lopende maand | +30,70% | ||
1 maand | +25,39% | ||
3 maanden | -12,35% | ||
6 maanden | +174,23% | ||
Lopend jaar | +0,90% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Jeff Borcherding
CEO | Chief Executive Officer | - | - |
Director of Finance/CFO | 62 | 01-04-22 | |
Karl Stone
COO | Chief Operating Officer | 61 | 01-03-23 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | 70 | 09-12-16 | |
Peter Andersen
CHM | Chairman | 67 | 01-01-20 |
Michael Löfman
BRD | Director/Board Member | - | 22-05-23 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
18-04-24 | 1,788 | +1,94% | 109 354 |
17-04-24 | 1,754 | -6,20% | 158 116 |
16-04-24 | 1,87 | +3,31% | 175 130 |
15-04-24 | 1,81 | +6,72% | 648 398 |
12-04-24 | 1,696 | -6,81% | 691 274 |
uitgestelde koers Nasdaq Stockholm, 18 april 2024 om 17:07 uur
Meer koersenVaira. 1 jan. | Kapi. | |
---|---|---|
+0,90% | 7,23 mln. | |
-48,09% | 2,59 mld. | |
+4,82% | 1,61 mld. | |
-12,79% | 1,43 mld. | |
+22,29% | 1,22 mld. | |
-14,90% | 979 mln. | |
-23,61% | 880 mln. | |
-9,43% | 718 mln. | |
-17,46% | 687 mln. | |
+3,77% | 474 mln. |